Mutations in human Cu,Zn-superoxide dismutase (SOD1) cause E20% of familial amyotrophic lateral sclerosis (FALS) cases. The mechanism of late-onset disease manifestation despite the innate mutation has no clear explanation. The relationship between homocysteine (HC) and amyotrophic lateral sclerosis (ALS) has not been investigated, in spite of the similarity in their pathogenesis. We investigated the e¡ect of HC on the motor neuronal cell-line transfected with SOD1 of either wild-type or one of two mutant forms (G93A and A4 V). In the MTT assay, HC induced signi¢cant cytotoxicity in A4V, but not in G93A, as compared with wild-type, even at the physiological concentration of 10 mM. This HC-induced cytotoxicity was inhibited by the antioxidant trolox and the Cu (I) chelator bathocuproinedisulfonate. Here we show that the vulnerability of the A4V mutant involves the cytotoxic copper-mediated pathway, and that HC may be a lifelong precipitating factor in some forms of FALS, suggesting the possible treatment modality with vitamin supplements. NeuroReport13:377^381
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder caused by selective death of motor neurons [1] . Such neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease, generally develop in old age, even though any susceptibility to selective neuronal damage has been partially elucidated to commence operation in early age. There is no clear explanation of the discrepancy.
About 10% of all ALS cases are familial, and numerous evidence has confirmed that the etiologies of sporadic (SALS) and familial ALS (FALS) share common mechanisms and that the study of FALS cases can provide an understanding of sporadic cases [1] . Twenty to 25% of FALS cases are associated with dominantly inherited mutations in Cu,Zn-superoxide dismutase (SOD1) [1] , a mutant which triggers the disease through one or more toxic properties including a dominant cytotoxic gain of function [2] . The biochemical nature of this toxic gain of function has remained elusive, but several mechanisms are currently postulated: enhancement of protein nitrosylation by mutant SOD1; enhanced peroxidase activity; exposure of toxic copper at the active site; and accumulation and aggregation of altered or abnormal proteins including SOD1 [1] .
Hyperhomocysteinemia is related to atherosclerosis, and even moderate elevations (15-20 mmol/l) are an important risk factor for vascular disease [3] . Parkinson's disease, Alzheimer-type dementia and other dementing illnesses have been reported to have an association with hyperhomocysteinemia [3] . Plasma homocysteine (HC) increases with age independent of vitamin status, and hyperhomocysteinemia is highly prevalent in the elderly [3, 4] .
A potential mechanism for the vascular effects of HC includes autoxidation of the thiol group, a reaction that produces a reactive oxygen species (ROS) such as superoxide anion and involves reduction of a transitional metal followed by reaction of the metal with molecular oxygen [5] . In addition, HC acts as an agonist at the NMDA subtype of the glutamate receptor [6] , and NO is scavenged to be transformed into peroxynitrite by reaction with the superoxide anion generated by HC [5] . Thiol autoxidation can also generate hydrogen peroxide and hydroxyl radicals [5] . Although these cytotoxic mechanisms of HC share many common pathways with those of ALS, there has been no report investigating the relationship between HC and ALS.
We hypothesized that in ALS, the HC continuously produced by diet and increasing with age might play a precipitating role in motor neuronal death resulting in ALS in old age, if motor neurons exhibit some vulnerability to cytotoxic injury such as the SOD1 mutation of FALS. We adopted the motor neuronal cell line as an in vitro model of ALS, which has mutant SOD1, and investigated the effect of HC on this cell.
MATERIALS AND METHODS
Cell culture: Motoneuron-neuroblastoma hybrid cells (ventral spinal cord 4.1 (VSC 4.1); a generous gift from Dr SH Appel, Baylor College of Medicine, USA) were maintained in log-phase growth on poly-L-ornithine-precoated culture dishes (Falcon) in Dulbecco's modified Eagles' medium/F-12 growth medium (Gibco, Grand Island, NY) with Sato's components (Sigma, St. Louis, MD) and 2% heatinactivated newborn calf serum (HyClone) at 371C. After confluency, the cells were plated in 96-well plates (NUNC) pre-coated with poly-(L-ornithine) at a density of 1 Â 10 4 cells per well. For immunoblot and SOD activity assay, some cells were seeded in poly-(L-ornithine)-precoated 100 mm dishes (Falcon) at a density of 1 Â 10
.
Constructs and establishing stable cell line: Human SOD-1 cDNA of normal and mutant cells were cloned into the BamHI and EcoRI1 sites of pcDNA 3.0 (Invitrogen, Carlsbad, CA), and the wild-type cells and mutant cells which have SOD1 with alanine substituted to valine at position 4, and those with glycine substituted to alanine at position 93, were designated as wild-type, A4V and G93A, respectively. These constructs were a gift from Dr Lawrence J. Hayward (University of Massachusetts, Boston, USA). Following the transfection (Superfect, Qiagen, Valencia, CA), the cells were maintained in a medium that contained G418 at a concentration of 400 mg/ml (Gibco, Grand Island, NY). Single or pooled colonies were used for the experiment after clarifying the expression of human SOD1 (WT, A4V, G93A) by Western blot analysis using an anti-human SOD1 polyclonal antibody (Calbiochem, La Jolla, CA). These cell lines were grown and differentiated under the same conditions as the VSC 4.1 cells.
SOD activity assay: SOD activity was assayed according to the procedures of Misura and Fridovich [7] . The activity was measured at 301C by determining the rate inhibiting epinephrine autoxidation in 50 mM sodium carbonate buffer (pH 10.2) and~30 ml 10 mM epinephrine to give a slope of 0.025 absorbance units/min at 480 nm. The amount of SOD in the sample required to inhibit the rate of epinephrine autoxidation by 50% was defined as one unit of activity, and expressed as unit/mg protein.
Neurocytotoxicity experiments: Twenty-four hours after plating, various concentrations of HC (1 mM-10 mM, Sigma, St. Louis, MD) were added for 24 h. To investigate the mechanism of HC-induced neurocytotoxicity, trolox (antioxidant, 0.3 mM), kynurenic acid (non-specific ionotrophic glutamate receptor blocker, 1 mM), 2-amino-5-phosphonovaleric acid (APV; NMDA receptor blocker, 100 mM), 6-cyano-7-nitroquidoxaline-2,3-dione (CNQX; AMPA/Kainate receptor blocker, 5 mM), No-nitro-L-arginine methyl ester (L-NAME; non-selective nitric oxide synthase (NOS) inhibitor, 1 mM), 7-nitroindazole (7-NI; relatively selective inhibitor of neuronal NOS inhibitor, 1 mM), 1H-[1,2,4] oxadiazolo-4,3-a-quinoxalin-1-one (ODQ; nitric oxide (NO)-dependent guanylyl cyclase inhibitor, 1 mM), and bathocuproinedisulfonate (BC; Cu (I)-specific chelator, 100 mM) were added to the cell culture for 30 min before the addition of HC. All the above drugs were purchased from Sigma (St. Louis, MO), except that trolox from Calbiocam (Sandiego, CA).
Cell viability assay: Cell viability was determined using a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltertazolium bromide (MTT) assay. In brief, MTT solution (5 mg/ml in PBS) was added to the cultures. After 3 h incubation the MTT solution was removed and the formazan precipitate was dissolved in 200 ml dimethyl sulfoxide (DMSO). Absorbance was measured at 540 nm using DMSO as a blank.
Statistics: Numerical results are expressed as mean 7 s.e.m. and significance was determined by the Wilcoxon rank sum test.
RESULTS
Western blot analysis was performed in VSC4.1, wild-type, A4 V, and G93A cell lysates with anti-human SOD1 antibody. We confirmed that as expected human SOD1 was expressed well in wild-type, G93A, and A4V, but not in VSC4.1 (data not shown here). The SOD enzyme activities of wild-type, G93A and A4V were measured, and they exhibited no difference [8] (data not shown here). Figure 1 shows the results of cell viability in G93A, A4V, and wild-type incubated with various concentrations of HC (1 mM-10 mM), expressed as a relative percentage to the viability of each cell line untreated with HC. The viability of all groups showed a decreasing tendency in a dosedependent manner, and wild-type was affected only at high concentrations of HC (71.7 7 3.8% in 10 mM). Although a more toxic tendency was observed in G93A than in wildtype, the difference was not significant. On the other hand, HC concentration of 10 mM-10 mM HC were significantly more toxic in A4V than in wild-type, an increase reaching 46 7 5.2% in 10 mM HC (p ¼ 0.011). Interestingly, a small but significant decrease in viability was observed in A4V treated with 10 mM HC (84.5 7 5.2%) compared with wild-type (109.4 7 7.2%, p ¼ 0.012).
To determine whether HC neurocytotoxicity involves oxidative injury, we tested the antioxidant trolox (Fig.  2a,b) . Exposure of the cultures to 0.3 mM trolox completely prevented the toxicity induced by 100 mM HC in A4 V from exhibiting significant cytotoxicity (Fig. 2a) , and this inhibition was also evident in 10 mM HC (Fig. 2b) . To investigate which mechanism was mediated among the postulated HC toxicity mechanisms, kynurenic acid, APV, CNQX, L-NAME, 7-NI, ODQ and BC were pretreated with A4V for 30 min, followed by the addition of HC (Fig. 3) . Whereas glutamate receptor antagonists, NOS inhibitors and NOdependent guanylyl cyclase inhibitor did not rescue cells from 1 mM HC toxicity, the decreased viability of A4V was reversed by BC, the Cu (I)-specific chelator (Fig. 3) .
DISCUSSION
The present study has shown that HC induced significant cytotoxicity in a dose-dependent manner in mutant SOD1-transfected motor neuronal cells (A4V, but not G93A), compared with its effect on wild-type SOD1-transfected cells. HC produces ROS including hydrogen peroxide, hydroxyl radical and superoxide [5, 9] . It is probably false to assume that this cytotoxicity results from the mutated SOD1 becoming deficient in dismutase activity and the superoxide produced by HC being undissolved. This selective cytotoxicity of HC to A4V can not be attributed to the loss of the enzyme function by mutation, because there was no difference in dismutase activity of either wildtype or mutants [8] (data not shown). This can not be explained without considering the cytotoxic gain of function of the SOD1 mutant. This report is the first to suggest that HC mediate cytotoxicity by toxic gain of function of mutant SOD1. We also found that this HC cytotoxicity was prevented by antioxidant and copper chelator, but not by glutamate receptor blockers, NOS inhibitors, or by NO-dependent guanylyl cyclase (Fig. 2, Fig. 3 ). HC acts as an agonist at the NMDA subtype of the glutamate receptor [6] as well as a producer of ROS. Our report indicates that this selective cytotoxicity of HC to A4V does not involve excitatory toxicity through HC's reaction as a glutamate 3 . The Cu (I) chelator, bathocuproinedisulfonate (BC), inhibited the homocysteine-induced selective cytotoxicity on A4 V. The various materials pretreated for 30 min before 1mM HC-treatment included; kynurenic acid (non-speci¢c ionotrophic glutamate receptor blocker,1mM), APV (NMDA receptor blocker, 100 mM), CNQX (AMPA/kainate receptor blocker, 5 mM), L-NAME (non-selective NOS inhibitor, 1mM), 7-NI (relatively selective inhibitor of neuronal NOS, 1 mM), ODQ (NO-dependent guanylyl cyclase inhibitor, 1 mM), and BC (Cu (I)-speci¢c chelator,100 mM). n = 6, *p = 0.028 determined by the Wilcoxon rank sum test, compared with the 1mM HC-treated group (¢rst gray bar).
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receptor agonist, and that major pathway is coppermediated ROS production [2] in the cytotoxicity of A4V.
A4V mutation in SOD1 may influence the efficiency of the reduction of the copper center by glutathione [10] , and in a yeast system the mutant SOD1 metal-free apoproteins lose their ability to bind copper at the proper sites whereas the wild type does not [11] . Expression of A4V mutant SOD1 causes the death of neuronal cells, which is prevented by copper chelators [12] . Thus, it is suggested that this HCinduced selective cytotoxicity is mediated by the copper exposed at the mutant SOD1 active site, since the copper chelator inhibited the HC-toxicity. While considering the postulated mechanism of toxic gain of function in SOD1 mutant, we did not exclude other mechanisms such as increased nitrosylation, peroxidase activity, and protein aggregation. However, the mutant enzyme is considered to catalyze the aberrant chemistry because the presence of less restrictive active sites arising from less tightly folded enzymes could conceivably allow greater access to the reactive copper of substrates such as peroxynitrite, hydrogen peroxide, or other small substances [13] . Thus, the exposure of toxic copper might play the major role in FALS pathogenesis. Flash photolysis and pulse radiolysis studies have demonstrated that peroxynitrite is formed via the very fast reaction between NO and superoxide, and that this rate is almost 10 times faster than the reaction between superoxide and SOD [14] . Therefore, our results suggest that the nitrosylation of intracellular substitution might have a negligible role, or at most partial role (Fig. 3) . Controversy exists as to the effect of hyperhomocysteinemia on NO production. Contrary reports have stated that HC can upregulate or down-regulate NO production [15, 16] , and this might lead to the little effect by NOS inhibitors on HC cytotoxicity.
In our results, HC did not induce significant cytotoxicity in G93A, compared with wild-type. The G93A mutant enzyme also generates free radicals as measured by the spin trapping method [17] and catalyzes the oxidation of a model substrate by hydrogen peroxide at a higher rate than that seen with the wild-type enzyme [18] . Catalysis of this reaction by G93A has also been considered to be due to copper exposure at the active site [18] . In this respect, HC would be more toxic to G93A than to wild-type. However, the Km value of the mutants for hydrogen peroxide is higher in the A4 V enzyme that in G93A [8] . The clinical presentation varies according to the mutation of SOD1 [19] . The A4 V mutation is more clinically severe than G93A [20] , and correlated with shorter survival [21] . Thus, difference in the toxic function of the mutants could explain our results, even though further investigation is required for G93A.
Interestingly, this HC-induced cytotoxicity was observed even at the typical physiologic concentration of 10 mM HC. HC levels are relatively stable throughout the first 4 decades of life but then rise sharply [3] . Modest hyperhomocysteinemia (15-50 mM) is found very commonly in the general population [22] . These results indicate that the motor neuronal cells containing the mutant SOD1 may be more susceptible to HC concentrations even as low as physiologic levels and to mild hyperhomocysteinemia, which can be induced by even usual diet, is common in old age, or by mild deficiency of vitamins. This could explain why FALS does not usually develop until adulthood, although the genetic abnormality is present innately from birth. The slow cell death process in FALS mouse models, where pathology occurs months before motor neuron loss, has not been explained well and it contrasts strikingly with the very rapid apoptotic death in in vitro studies [23] . Furthermore, even in SALS, there has been no clear explanation why ALS develops in old age, in spite of the possibility of an early operation of susceptible mechanism of motor neurons to cytotoxic injury. In light of the results of this study, HC is indeed lifelong precipitating factor in some form of FALS, and possibly in SALS. Since elevated HC in principle is more readily treatable with vitamin supplements, our finding has the possibility to generate considerable clinical implications.
CONCLUSION
We demonstrated that HC displayed a greater cytotoxic effect on motor neuronal cells transfected with the SOD1 mutant (A4V, but not G93A) than on those transfected with the wild-type SOD1, and that this cytotoxicity involved the ROS production of copper exposed by the conformational change of mutant as a toxic gain of function. This HCinduced selective cytotoxicity was observed even at the low physiological concentration of 10 mM HC. This HC-induced mutant cytotoxicity was inhibited by the antioxidant trolox and the Cu (I) chelator bathocuproinedisulfonate. This result suggests that HC is a lifelong precipitating factor in some form of FALS pathogenesis, and possibly in SALS, suggesting the possible treatment modality with vitamin supplements.
